← BIO-RAD LABORATORIES, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $28.1m | $122.2m | $365.6m | $1.8b | $3.8b | $4.2b | ($3.6b) | ($637.3m) | ($1.8b) | $759.9m | |
| Depreciation, Depletion and Amortization | $142.9m | $148.7m | $138.1m | $134.2m | $138.1m | $133.8m | $137.3m | $145.9m | $151.6m | $165.4m | |
| Amortization of Intangible Assets | $35.2m | $30.8m | $28.3m | $23.5m | $27.5m | $28.4m | $24.9m | $23.8m | $21.2m | $23.8m | |
| Depreciation | — | — | — | — | — | — | — | — | — | $141.4m | |
| Depreciation, Amortization and Accretion, Net | — | — | — | $40.3m | $37.1m | $39.3m | $39.9m | $46.5m | $41.2m | $40.0m | |
| Deferred Income Tax Expense (Benefit) | ($51.2m) | ($84.8m) | $120.9m | $450.2m | $979.0m | $1.1b | ($1.2b) | ($322.6m) | ($626.8m) | $170.5m | |
| Share-based Payment Arrangement, Noncash Expense | $19.7m | $23.4m | $27.8m | $35.6m | $41.6m | $51.2m | $60.9m | $61.3m | $62.3m | $58.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | $8.9m | $8.1m | $12.9m | $22.5m | $14.0m | $14.9m | $3.4m | $3.0m | |
| Share-based Payment Arrangement, Expense | $19.7m | $23.4m | $27.8m | $35.6m | $41.6m | $51.2m | $60.9m | $61.3m | $62.3m | $58.0m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | $800k | $11.9m | $0 | $0 | $6.0m | |
| Goodwill, Impairment Loss | $13.5m | $11.5m | $282.0m | $0 | $0 | $0 | $0 | $0 | — | — | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | — | — | — | — | $172.8m | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $46.4m | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Assets | — | — | $4.1m | $0 | $0 | — | — | — | — | — | |
| Gain (Loss) on Disposition of Business | — | — | — | — | ($11.7m) | $0 | ($1.4m) | ($2.5m) | $0 | $0 | |
| Gain (Loss) on Disposition of Other Assets | — | — | $5.1m | $0 | $11.7m | $0 | $1.4m | $0 | $0 | — | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($600k) | ($8.1m) | ($2.0m) | ($1.2m) | ($1.1m) | ($120.8m) | ($112.8m) | ($156.7m) | ($165.6m) | ($157.6m) | |
| Income Tax Expense (Benefit) | $13.4m | ($24.4m) | $147.0m | $502.4m | $1.1b | $1.2b | ($1.1b) | ($212.8m) | ($498.3m) | $235.6m | |
| Other Nonoperating Income (Expense) | $14.8m | $12.2m | $36.6m | $26.1m | $24.5m | $26.8m | $44.6m | $106.4m | $90.3m | $90.3m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | ($12.5m) | $64.1m | ($59.7m) | ($1.6m) | $15.0m | $20.4m | $87.4m | ($11.4m) | ($16.2m) | ($19.6m) | |
| Increase (Decrease) in Inventories | $57.1m | $47.7m | $12.9m | ($24.2m) | $52.1m | ($46.1m) | $158.8m | $46.3m | ($8.5m) | ($68.9m) | |
| Debt and Equity Securities, Gain (Loss) | — | — | $1.6m | $1.5m | $700k | — | — | — | — | — | |
| Debt and Equity Securities, Unrealized Gain (Loss) | — | — | — | — | — | $4.9b | ($5.2b) | ($1.3b) | ($2.7b) | $900.4m | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | — | — | — | — | — | — | $100.6m | $6.8m | ($12.5m) | ($12.4m) | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($4.5m) | ($9.1m) | ($2.9m) | ($2.2m) | ($1.8m) | ($2.8m) | $205k | $7.3m | $3.9m | $6.6m | |
| Foreign Currency Transaction Gain (Loss), Realized | — | — | — | — | — | — | ($19.9m) | $9.9m | ($20.7m) | $43.5m | |
| Goodwill | $477.1m | $506.1m | $219.8m | $264.1m | $291.9m | $347.3m | $406.5m | $413.6m | $410.5m | $579.8m | |
| Marketable Securities, Unrealized Gain (Loss) | — | — | — | — | — | — | — | — | ($2.7b) | $900.4m | |
| Nonoperating Income (Expense) | $0 | — | — | — | — | — | — | — | — | — | |
| Provision for Loan, Lease, and Other Losses | — | — | — | — | — | — | $7.5m | $0 | $0 | $1.4m | |
| Realized Investment Gains (Losses) | $800k | $100k | $1.6m | $1.5m | $1.0m | $8.0m | $2.3m | $700k | $6.7m | $1.0m | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $2.3b | $2.3b | $2.5b | $2.9b | $2.8b | $2.7b | $2.6b | $2.6b | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | ($1.2m) | $0 | ($900k) | ($1.3m) | $1.2m | ($200k) | ($1.3m) | ($2.2m) | ($1.3m) | |
| Net Cash Provided by (Used in) Operating Activities | $216.4m | $103.9m | $285.5m | $457.9m | $575.3m | $656.5m | $194.4m | $374.9m | $455.2m | $532.2m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $141.4m | $111.3m | $129.8m | $98.5m | $98.9m | $120.8m | $112.8m | $156.7m | $165.6m | $157.6m | |
| Payments to Acquire Investments | $278.1m | $282.7m | $371.0m | $371.4m | $248.5m | $851.6m | $2.1b | $689.0m | $1.3b | $669.3m | |
| Payments for (Proceeds from) Other Investing Activities | — | — | — | — | ($3.4m) | $0 | $1.4m | $0 | $0 | — | |
| Net Cash Provided by (Used in) Investing Activities | ($213.9m) | ($175.6m) | ($187.0m) | ($208.9m) | ($60.2m) | ($784.4m) | ($1.2b) | $20.2m | ($160.2m) | ($189.7m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $143.0m | $202.2m | $225.3m | $226.9m | $278.3m | $341.4m | $357.8m | $361.3m | $199.3m | $62.0m | |
| Repayments of Long-term Debt | $303k | $316k | $3.0m | $643k | $426.9m | $3.0m | $510k | $467k | $400k | $500k | |
| Proceeds from Issuance of Common Stock | $11.3m | $7.3m | $14.1m | $5.0m | $7.3m | ($1.9m) | ($3.4m) | $18.5m | $19.2m | $15.8m | |
| Payments for Repurchase of Common Stock | — | $2.9m | $48.9m | $28.0m | $100.0m | $50.0m | $215.7m | $428.7m | $203.6m | $295.5m | |
| Net Cash Provided by (Used in) Financing Activities | $9.0m | $341k | ($48.7m) | ($22.8m) | ($523.0m) | ($55.4m) | $973.6m | ($425.6m) | ($218.8m) | ($283.2m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | $4.5m | ($196.0m) | ($36.6m) | ($30.2m) | $85.4m | $42.4m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $434.2m | $662.7m | $667.1m | $471.1m | $434.5m | $404.4m | $489.8m | $532.2m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Income Taxes Paid, Net | $38.4m | $52.1m | $62.4m | $45.1m | $65.2m | $134.7m | $158.3m | $129.6m | $99.4m | $61.6m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.